Drugs / Zunveyl®
Zunveyl®
also known as
ALPHA-1062 gluconate · Benzgalantamina · BENZGALANTAMINE GLUCONATE · Galantamine benzoate gluconate · GLN-1062 gluconate · Memogain gluconate
Small molecule targets ACHE via inhibition
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Filed | China (NMPA) | ZUNVEYL | mild-to-moderate Alzheimer’s dementia | 2025-07-29 | “New Drug Application (NDA) for ZUNVEYL has been accepted by the National Medical Products Administration of China (NMPA) for review” alphacognition.com ↗ |
| Approved | US (FDA) | ZUNVEYL | — | 2024-07-26 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07633470 | May 2026 → Apr 2027 expected | Alzheimer disease | Alpha Cognition, Inc | Recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 5
All press releases naming this drug 15 releases
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zunveyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07633470 ↗ |
| Known as | ALPHA-1062 gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Known as | Benzgalantamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Known as | BENZGALANTAMINE GLUCONATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Known as | Galantamine benzoate gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Known as | GLN-1062 gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Known as | Memogain gluconate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095056 ↗ |
| Action | Inhibit | “Acetylcholinesterase inhibitor” CHEMBL5095056 ↗ |
| Modality | Small molecule | — CHEMBL5095056 ↗ |
| Route | Oral | “Zunveyl® delayed release oral tablets.” NCT07633470 ↗ |
| Target | ACHE | “Acetylcholinesterase inhibitor” CHEMBL5095056 ↗ |